Merz Aesthetics Announces FDA Approval Of Belotero Balance

Posted on the 24 November 2011 at 09:58

Merz Aesthetics have announced FDA approval of BELOTERO balance® dermal filler for the correction of moderate-to-severe facial wrinkles and folds.

BELOTERO Balance® Dermal Filler is the newest addition to the Merz Aesthetics™ expanding portfolio of intelligently designed products and the second Merz Aesthetics FDA approval in 2011.  Joining exisiting products BELOTERO SOFT® and BELOTERO INTENSE® that are currently available in the UK.

"BELOTERO Balance® is a soft dermal filler that is designed to achieve meaningful results by integrating into facial skin tissue," said Rhoda S. Narins, M.D., lead investigator and Clinical Professor of Dermatology at New York University Medical School, New York, N.Y. "With BELOTERO Balance®, patients are able to see a visible softening in their lines for a natural look that lasts."

BELOTERO Balance® filler is a hyaluronic acid-based cohesive gel dermal filler designed to deliver natural-looking results with little recovery time. BELOTERO® filler is currently approved for aesthetic use in the United Kingdom (Under the Name BELOTERO BASIC®), Germany, Italy, Russia, Austria and Switzerland.

"BELOTERO Balance® Dermal Filler is an important addition to our expanding portfolio of aesthetic products in the United States," said Dennis Condon, President and CEO of Merz Aesthetics, Inc. "The availability of BELOTERO Balance® provides physicians with a new option for patients seeking treatment with a dermal filler."

The FDA approval of BELOTERO Balance® Dermal Filler is based on the results from a randomized, double-blind, active-controlled, multicenter study of 118 patients. In a split face design, patients received bilateral treatment with BELOTERO Balance® filler and an approved bovine collagen (COL) filler for the correction of their moderate-to-severe nasolabial folds (NLFs).

Patients were evaluated using a five-point Wrinkle Severity Scale (WSRS), ranging in severity from least (0) to most (4). BELOTERO Balance® Dermal Filler demonstrated greater reduction in the mean change of the WSRS at all-time points and maintained more than 1 point WSRS reduction at week 24 (compared to 0.5 for the control).

No serious adverse events (AEs) were reported in this study for either treatment. Commonly occurring, short-term injection site reactions, including swelling, bruising and injection site nodules, were mild to moderate in severity.

Important BELOTERO Balance® Dermal Filler Treatment Considerations

BELOTERO Balance® Dermal Filler is FDA-approved for injection into the dermis for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds. After injection, patients may experience redness, bruising, swelling or other local side effects. More rare side effects may include swelling that lasts longer, unevenness or firmness in the area injected, and as with any injection, there may be a risk of infection.

Add Comment

To leave a comment you need to be logged in as a Cosmetic Community Member or a Clinic.

Please Click Here to login / register with the Cosmetic Community.

If you are a Clinic Click Here to login to the partners area of Consulting Room.

Blog Comment(s) [2]

I had tried this product to minimize the line around my mouth. The product was recomended to me by the surgeons office as being great at reducing the lines I say are from many years of smoking. (I quit 5 years ago) I was not happy with the results and complained and was told by the surgeon that it looked good and could not see why I was not happy. I see my face everyday he has only seen it a couple of times. I know when there is a difference in my apperience and believe me there was no difference. Would not recomend this product for lines around your mouth at all.


I agree that Belotero is not "man" enough for perioral lines. I had Belotero Soft only five days ago and already the lines are back. Are they better than before treatment? Possibly. Is that good enough? No.

Truffle McShoe